Axon Enterprise, Inc $AXON Shares Bought by Swedbank AB

Swedbank AB boosted its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 1.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 110,683 shares of the biotechnology company’s stock after buying an additional 1,820 shares during the quarter. Swedbank AB’s holdings in Axon Enterprise were worth $62,860,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Creative Financial Designs Inc. ADV acquired a new stake in Axon Enterprise during the 4th quarter worth approximately $28,000. New Millennium Group LLC acquired a new stake in Axon Enterprise during the 3rd quarter worth approximately $29,000. Sound Income Strategies LLC lifted its holdings in Axon Enterprise by 550.0% during the 4th quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock worth $30,000 after buying an additional 44 shares in the last quarter. Camelot Portfolios LLC acquired a new stake in Axon Enterprise during the 4th quarter worth approximately $30,000. Finally, Root Financial Partners LLC acquired a new stake in shares of Axon Enterprise in the 3rd quarter valued at $34,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, insider Isaiah Fields sold 2,000 shares of Axon Enterprise stock in a transaction on Friday, February 27th. The shares were sold at an average price of $535.01, for a total transaction of $1,070,020.00. Following the sale, the insider directly owned 55,588 shares in the company, valued at $29,740,135.88. This trade represents a 3.47% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction on Wednesday, February 25th. The stock was sold at an average price of $500.24, for a total transaction of $5,002,400.00. Following the sale, the chief executive officer owned 3,090,997 shares in the company, valued at $1,546,240,339.28. This represents a 0.32% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 13,855 shares of company stock worth $7,109,828 over the last three months. Company insiders own 4.20% of the company’s stock.

Axon Enterprise Price Performance

Shares of AXON opened at $386.00 on Friday. The firm’s fifty day simple moving average is $416.52 and its 200-day simple moving average is $503.10. Axon Enterprise, Inc has a twelve month low of $339.01 and a twelve month high of $885.91. The company has a current ratio of 2.27, a quick ratio of 1.93 and a debt-to-equity ratio of 0.49. The firm has a market capitalization of $31.11 billion, a price-to-earnings ratio of 155.02, a PEG ratio of 7.02 and a beta of 1.44.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 EPS for the quarter, topping the consensus estimate of $1.60 by $0.01. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The firm had revenue of $807.35 million for the quarter, compared to analyst estimates of $778.91 million. During the same period last year, the business earned $1.47 EPS. Axon Enterprise’s revenue for the quarter was up 33.7% compared to the same quarter last year. Equities analysts forecast that Axon Enterprise, Inc will post 1.82 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

AXON has been the topic of a number of analyst reports. Wall Street Zen upgraded shares of Axon Enterprise from a “sell” rating to a “hold” rating in a report on Saturday, February 28th. Needham & Company LLC reduced their price objective on shares of Axon Enterprise from $870.00 to $600.00 and set a “buy” rating on the stock in a report on Friday, February 20th. Weiss Ratings upgraded shares of Axon Enterprise from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, May 8th. William Blair restated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 3rd. Finally, Zacks Research upgraded shares of Axon Enterprise from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 19th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $712.75.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.